BMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement Post author:GHIAA Admin Post published:September 5, 2024 Post category: Continue ReadingBMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement
AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingAbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement
AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) License Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingAbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) License Agreement
Pfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingPfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CARB-X Portfolio Company Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingCARB-X Portfolio Company Agreement
BMS – MPP, HIV Antiretroviral (atazanavir – ATV) License and Technology Transfer Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingBMS – MPP, HIV Antiretroviral (atazanavir – ATV) License and Technology Transfer Agreement
Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement